The Oncology Nursing Podcast: UC expert discusses antimetabolite drugs
The University of Cincinnati's Rowena Schwartz joined The Oncology Nursing Podcast to discuss what oncology nurses need to know about a class of chemotherapy drugs called antimetabolites.
Schwartz, PharmD, said antimetabolites are some of the oldest anti-cancer drugs that are "developed to be similar to naturally occurring compounds that are important in cell production." They work in different ways to accomplish the goal of killing cancer cells, and also have uses as antibacterial drugs, she said.
Each drug has different potential side effects, and even the same drug can have different side effects when given at different doses and regimens, Schwartz said, highlighting the need for every member of an oncology care team to be familiar with each specific drug, dose and regimen.
"If I don’t use a drug often, I will always look it up again before I do any kind of education for a patient," said Schwartz, professor of pharmacy practice at UC's James L. Winkle College of Pharmacy. "If I don’t use [a drug] routinely in my practice, I always find myself reviewing it just to make sure that a nuanced side effect that may be very important for a patient, I will go over."
Patient education is a job for the whole team, Schwartz said, and there needs to be collaboration between doctors, nurses and pharmacists.
"I think that in this day and age it is really important that there’s collaboration in developing whatever resources that we have," she said. "I guess that goes even beyond order sets to the education we deliver to patients to make sure it’s a consistent message. I think that is essential that the team knows what everybody is going to say so that it is consistent, because patients get so confused."
Even though antimetabolites are an older type of drug, Schwartz said she believes they will remain an important part of cancer treatment.
“I think that there are certain agents that are so foundational in some diseases that they will remain. Whether they remain first-line, maybe not; maybe they’ll go to second line as we see things evolve with new agents," she said. "Some of these drugs have been very effective in the diseases in which they are used to treat patients. There’s a long term place in therapy for these, and I think that we'll still be using these.”
Listen to The Oncology Nursing Podcast.
Featured photo at top of hospital room. Photo/Dmitri Karastelev/Unsplash.
Related Stories
UC Named Lead Organization for OSHA Training Consortium
January 13, 2003
UC Continuing Medical Education (CME) has been selected as the lead organization for the Occupational Safety and Health Administration (OSHA) Great Lakes Training Consortium by the U.S. Department of Labor.
Ignorance of Stroke s Warning Signs a Barrier to Treatment; More Education Needed, UC Researchers Report in JAMA
January 14, 2003
Demographic groups facing the greatest risk of death and disability from stroke are the least likely to recognize stroke s warning signs and risk factors, according to a study by UC researchers published in the January 15 issue of the Journal of the American Medical Association (JAMA).
UC Researchers Find New Link Between the Eye and the Clock in the Brain
January 21, 2003
Results of a study done by a team of researchers working in the laboratories of Michael Lehman, PhD, professor, Department of Cell Biology, Neurobiology, and Anatomy at the UC College of Medicine, will appear in the February issue of Nature Neuroscience.
Leader of Fetal Surgery to Deliver Lectures at UC
January 31, 2003
An internationally recognized authority on fetal surgery will lecture at the UC Medical Center, representing the first of a series of lectures on fetal surgery presented by the department of Obstetrics and Gynecology (Ob/Gyn).
UC Celebrates National Heart Failure Awareness Week
January 31, 2003
UC Medical Center physicians Lynne Wagoner, MD, and Harvey Hahn, MD, are teaming up with The University Hospital to celebrate National Heart Failure Awareness Week, Feb. 10-14, 2003.
UC College of Nursing Announces New Scholarship for Graduate Program
January 31, 2003
The UC College of Nursing announces the availability of a new scholarship for a full-time student in the Women s Health Graduate Nursing Program.
Inaugural Paul B. Hammond Award Goes To NIEHS Director
February 7, 2003
In a ceremony held Jan. 14, 2003, Kenneth Olden, PhD, director of the National Institute of Environmental Health Sciences (NIEHS) and the National Toxicology Program (NTP), received the inaugural Paul B. Hammond award.
UC Stroke Researcher Receives Award from American Stroke Association
February 13, 2003
Joseph Broderick, MD, chair of the University of Cincinnati (UC) Department of Neurology, received the 2003 William M. Feinberg Award for Excellence in Clinical Stroke from the Stroke Council of the American Stroke Association.
NetWellness Experts Answer 20,000th Question
February 18, 2003
Mitchell Rashkin, MD, professor of internal medicine, pulmonary division, at theUniversity of Cincinnati (UC) recently answered the 20,000th question for NetWellness.
UC Partners with Universities in Ohio and Kentucky to Promote Economic Development
February 18, 2003
Four major research universities in Ohio and Kentucky are collaborating to promote economic development in life sciences and biotechnology.